Dr. Richard Wenzel is a Principal in the Life Sciences Practice at CRA’s Munich office with 7+ years consulting experience. He specializes in strategy for innovative therapies, developing fact-based commercial models with clear methodology and measurable business impact.
Richard works across a broad spectrum of therapeutic areas delivering implementable results on (portfolio) strategy, patient identification, pricing, and launch excellence and more. He is a speaker at industry events, e.g. WODC.
Prior to joining CRA, Richard worked as a Senior Consultant for the Simon-Kucher life sciences division in Germany and the US.